GleamWall
中文EN

MCUJF MEDICURE INC IFRS

Pharmaceutical Preparations · OTC · SEC CIK 1133519 · Reporting currency CAD · Fiscal year ends 12/31

Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY1.0%
TTM net income YoY-12.7%
TTM EPS YoY-11.1%
Revenue 3-yr CAGR0.2%
Net income 3-yr CAGR—

Margins

Gross margin59.7%
Operating margin—
Net margin-4.7%
FCF margin—
EBITDA margin—

Returns

ROE-5.1%
ROA-3.6%
ROIC (approx.)—
Asset turnover0.76x

Leverage & solvency

Liabilities / assets30.0%
Debt / equity0.00x
Current ratio1.89x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-1.33x
Accruals ratio-8.4%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Unit: CAD FY2024*2024-12-31FY2023*2023-12-31
Income statement
Revenue21.91M21.69M
Cost of revenue8.82M7.71M
Gross profit13.09M13.99M
R&D expense3.08M2.41M
SG&A expense4.76M4.13M
Pretax income-783,000-897,000
Income tax-256,000-25,000
Net income-1.04M-922,000
EPS (basic)-0.10-0.09
EPS (diluted)-0.10-0.09
Weighted avg. shares (diluted)10.44M10.44M
Balance sheet
Cash & equivalents7.19M6.37M
Receivables5.30M4.79M
Inventory3.28M2.90M
Current assets15.90M15.21M
PP&E, netmay include right-of-use assets (IFRS)955,000736,000
Goodwill3.38M3.10M
Intangibles9.35M8.94M
Total assets29.68M28.06M
Current liabilities8.39M7.93M
Total liabilities8.90M8.16M
Shareholders' equity20.78M19.90M
Cash flow statement
Operating cash flow1.38M2.08M
Investing cash flow-739,000-270,000
Financing cash flow-370,000-297,000
Stock-based compensation196,000288,000

Free plan shows the latest 2 periods; Pro shows all 10 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· Amounts are in the company's reporting currency, CAD, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.